Impact Factor
3.57
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.03
738 total citations
h5-index
36
h5 depth signal
Cited share
76.9%
196 of 255
Total citations
738
Citation footprint
Metric signal
3.74
External metric anchor
Self-citation
2.8%
21 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
347
China
164
United Kingdom
155
Japan
136
Australia
109
Citing Fields of Research
Pharmacology & Toxicology
273
Cardiology
126
Cellular Membrane Transporters & Receptors
115
Cancer Drugs
108
Anesthetic & Pain Medicine
76
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,565
Articles tracked across the journal lifetime
Indexed publication set
255
196 cited publications
Last 12 months
146
12.2 publications/month
Open access share
100.0%
146 OA publications in the last year
Leading citing country
United States
347 citing publications
Leading citing field
Pharmacology & Toxicology
273 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v5n1, Feb. 2017-
v1n1, 2013-
Active Coverage
Research Focus & Classification
Indexed Subjects
Pharmacology & Toxicology
Antibiotic & Antibacterial Agents
Education & Pedagogy
Cardiology
Patient Care
Hematology
Anesthetic & Pain Medicine
Issuing & Sponsoring Bodies
issuing body
British Pharmacological Society
issuing body
American Society for Pharmacology and Experimental Therapeutics
Broad Categories
Pharmacology
Substance Abuse
Pharmacology & Toxicology
Cellular Membrane Transporters & Receptors
Cardiology
Hematology
Neurosciences
Medical Ethics
MeSH Descriptors
Drug Discovery
Pharmacological Phenomena
Translational Research, Biomedical.
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/prp2.70337
Open DOI
Comparative Pharmacokinetics and Safety of Orally Disintegrating and Conventional Tablet Formulations of Zastaprazan in Healthy Subjects
Zastaprazan, a potassium‐competitive acid blocker, has been developed as an orally disintegrating tablet (ODT) to improve administration flexibility. This study evaluated the pharmacokinetics and safety of a single 20 mg dose of Zastapra...
02
DOI 10.1002/prp2.70334
Open DOI
Astragaloside IV and Ferroptosis Modulation in Pathological Cardiac Hypertrophy: Current Evidence, an Integrative Hypothesis, and Future Directions
Pathological cardiac hypertrophy is initially an adaptive response to sustained mechanical, neurohormonal, or metabolic stress; however, it can progress to fibrosis, contractile dysfunction, arrhythmia, and heart failure. Ferroptosis is ...
03
DOI 10.1002/prp2.70331
Open DOI
Adrenergic Contraction of Human Prostate Tissues Is Maintained Under the Rab GTPase Inhibitors Nexhinib20 and CID1067700
α 1 ‐Adrenoceptors are an important drug target in benign prostatic hyperplasia (BPH) and have been intensively studied at the expression level, but their posttranslational regulation in the prostate is widely unknown. Here we examined m...
04
DOI 10.1002/prp2.70333
Open DOI
Maintaining IV Patency Throughout Pharmacokinetic Studies Through a Needle‐Free Blood Draw Device
Pharmacokinetic (PK) studies require temporally precise measurements of drug concentrations in biological matrices, most commonly whole blood or plasma. However, repeated venous sampling may increase participant burden and complicate PK‐...
05
DOI 10.1002/prp2.70322
Open DOI
Chios Mastic in Well‐Controlled Hypertension: Findings From the HYPER ‐ MASTIC Randomized Controlled Trial
Residual cardiovascular risk persists in patients with adequately controlled hypertension, driven partly by inflammation, oxidative stress and endothelial dysfunction. Chios mastic ( Pistacia lentiscus var. Chia ) has shown antihypertens...
06
DOI 10.1002/prp2.70270
Open DOI
Issue Information
07
DOI 10.1002/prp2.70330
Open DOI
Metformin Inhibits Ferroptotic Cell Death by Suppressing Cysteine Deprivation‐Induced Mitochondrial Dysfunction
Ferroptosis, an iron‐dependent form of regulated cell death driven by excessive lipid peroxidation, has emerged as a promising therapeutic strategy for cancer. Metformin, a widely used biguanide antidiabetic drug, has recently been repor...
08
DOI 10.1002/prp2.70329
Open DOI
Glucagon‐Like Peptide‐1 Agonists and Blood Pressure Regulation: Molecular Mechanisms and Cardiovascular Implications
Incretin effect helps in regulating glucose homeostasis and maintaining glycaemic control within the human body. This effect is achieved by the two naturally occurring incretin hormones: glucose‐dependent insulinotropic polypeptide (GIP)...
09
DOI 10.1002/prp2.70318
Open DOI
The Bile Acid Signaling Axis: Deciphering the Roles of FXR and TGR5 in Hepatic Steatosis, Fibrosis, and Cancer
Bile acids (BAs) serve not only as emulsifiers for lipid digestion but also as essential signaling molecules, governing various physiological and pathological processes through their interaction with the farnesoid X receptor (FXR) and th...
10
DOI 10.1002/prp2.70328
Open DOI
Improving Medication Management in Indonesian Aged Care Homes: Research Priority Setting With Stakeholders
Indonesia and other Southeast Asian nations are experiencing rapidly aging populations. The Indonesian Government recently announced a national initiative of aged care homes to support older people not able to live independently or recei...